United States HR 7658: To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Status: Introduced in House (as of 2022-05-03)

State: United States · Session: 117 · Bill: HR 7658

Sponsors: Tom O'Halleran, Debbie Lesko

View United States HR 7658 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.